Raffles Medical GroupRAFLF 57 Market Cap is $1,300.5 Mil as of Jul. 01, 2026. GuruFocus rates RAFLF with a GF Score™ of 57/100 and a GF Value™ of $0.75 (Fairly Valued). The stock has 4 warning signs investors should review. Among 695 Healthcare Providers & Services companies, Raffles Medical Group ranks better than 83.88% on this metric.
Raffles Medical Group's quarterly market cap
increased
from Dec. 2024 ($1,239.6 Mil) to Jun. 2025 ($1,388.2 Mil) but then
declined
from Jun. 2025 ($1,388.2 Mil) to Dec. 2025 ($1,324.9 Mil).
Raffles Medical Group's annual market cap
declined
from Dec. 2023 ($1,433.4 Mil) to Dec. 2024 ($1,239.6 Mil) but then
increased
from Dec. 2024 ($1,239.6 Mil) to Dec. 2025 ($1,324.9 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Raffles Medical Group's Enterprise Value for Today is $1,126.1 Mil.
Raffles Medical Group (OTCPK:RAFLF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Raffles Medical Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raffles Medical Group Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Raffles Medical Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Raffles Medical Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Raffles Medical Group's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raffles Medical Group (RAFLF) has a Market Cap of $1,300.5 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Raffles Medical Group and its competitors. According to the industry distribution chart, Raffles Medical Group ranks #112 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 16.1%.
Is Raffles Medical Group's Market Cap too high?
Raffles Medical Group's current Market Cap is $1,300.5 Mil. The Healthcare Providers & Services industry median Market Cap is 95.72. Raffles Medical Group's value of $1,300.5 Mil is 1258.7% above this industry median. Based on the distribution chart, Raffles Medical Group ranks #112 out of 695 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Raffles Medical Group has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Raffles Medical Group's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Raffles Medical Group ranks #112 out of 695 companies for Market Cap. This places Raffles Medical Group in the top 16% of its industry — outperforming the majority of peers. The industry median Market Cap is 95.72. Raffles Medical Group's value of $1,300.5 Mil is 1258.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 95.72, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Raffles Medical Group's current Market Cap of $1,300.5 Mil is 1258.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Raffles Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 95.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Raffles Medical Group's current Market Cap is $1,300.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raffles Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Raffles Medical Group (RAFLF) is currently considered Fairly Valued. The stock's GF Value™ is $0.75, compared to a current price of $0.75 — trading 0.4% above its estimated fair value. The current Market Cap is $1,300.5 Mil and 1258.7% above the Healthcare Providers & Services industry median of 95.72. Raffles Medical Group's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Raffles Medical Group (RAFLF), the current Market Cap is $1,300.5 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Raffles Medical Group (RAFLF) Overvalued in 2026?
Based on GuruFocus' analysis, Raffles Medical Group stock appears to be overvalued.
The current stock price of $0.75 is trading 0.4% above its estimated GF Value™ of $0.75.
GuruFocus considers Raffles Medical Group to be Fairly Valued.
Key valuation signals for RAFLF:
Market Cap: $1,300.5 Mil
GF Value™: $0.75 vs. price of $0.75 (0.4% above fair value)
Industry Position: 1258.7% above the Healthcare Providers & Services median (#112 of 695)
No single metric tells the full story. See the RAFLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The company's operating segment includes Healthcare services, Hospital Services, Investment Holdings, and Insurance Services. The company generates revenue from contracts with customers, Rental Income, and Insurance revenue. Geographically operates in Singapore, Greater China, Vietnam, Cambodia and Japan.
57GF Score
Get the complete analysis for RAFLF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RAFLF has been successfully added to your 
